Pharmacogenetic Studies of Paclitaxel in Ovarian Cancer : focus on interindividual differences in pharmacodynamics and pharmacokinetics

Pharmacogenetic Studies of Paclitaxel in Ovarian Cancer : focus on interindividual differences in pharmacodynamics and pharmacokinetics

Ovarian cancer is one of the most common female cancer diseases in the world today and in Sweden more than 800 new cases are diagnosed every year. The standard treatment consists of chemotherapy with paclitaxel in combination with carboplatin after initial cytoreductive surgery. The response to trea...

Full description

Bibliographic Details
Main Author: Green, Henrik
Format: Doctoral Thesis
Language:English
Published: Linköpings universitet, Klinisk farmakologi 2007
Subjects:
pharmacogenetics
paclitaxel
LC/MS
Taxol
ovarian cancer
pharmacokinetics
CYP2C8
CYP3A4
ABCB1
äggstockscancer
paklitaxel
Clinical pharmacology
Klinisk farmakologi
Online Access:http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-8134
http://nbn-resolving.de/urn:isbn:978-91-85715-84-8

Internet

http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-8134
http://nbn-resolving.de/urn:isbn:978-91-85715-84-8

Similar Items